CORRECTED-BRIEF-Merck says continues to believe in osteoporosis drug

Fri Feb 1, 2013 9:58am EST

(Corrects spelling of drug)

Feb 1 (Reuters) - Feb 1 (Reuters) - Merck & Co Inc : * CEO says continues to believe in potential of osteoporosis drug odanacatib * Said it made decision to delay seeking U.S. approval of drug on its own, without FDA prodding * Says it will delay marketing application in order to include additional data from an extension trial (Reporting By Ransdell Pierson)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.